SG43833A1 - Sucrose ester-c20 to c25 alcohol formulations - Google Patents

Sucrose ester-c20 to c25 alcohol formulations

Info

Publication number
SG43833A1
SG43833A1 SG1996001710A SG1996001710A SG43833A1 SG 43833 A1 SG43833 A1 SG 43833A1 SG 1996001710 A SG1996001710 A SG 1996001710A SG 1996001710 A SG1996001710 A SG 1996001710A SG 43833 A1 SG43833 A1 SG 43833A1
Authority
SG
Singapore
Prior art keywords
sucrose ester
sucrose
alcohol formulations
formulations
alcohol
Prior art date
Application number
SG1996001710A
Other languages
English (en)
Inventor
David H Katz
Mohammed H Khalil
John F Marcelletti
Laura E Pope
Lee R Katz
Original Assignee
Lidak Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lidak Pharmaceuticals filed Critical Lidak Pharmaceuticals
Publication of SG43833A1 publication Critical patent/SG43833A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SG1996001710A 1993-12-13 1994-09-02 Sucrose ester-c20 to c25 alcohol formulations SG43833A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16652393A 1993-12-13 1993-12-13

Publications (1)

Publication Number Publication Date
SG43833A1 true SG43833A1 (en) 1997-11-14

Family

ID=22603672

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996001710A SG43833A1 (en) 1993-12-13 1994-09-02 Sucrose ester-c20 to c25 alcohol formulations

Country Status (15)

Country Link
US (1) US5534554A (de)
EP (2) EP1473031B1 (de)
JP (2) JP4149511B2 (de)
KR (1) KR100322507B1 (de)
CN (2) CN1103586C (de)
AT (2) ATE383848T1 (de)
AU (1) AU693476B2 (de)
CA (1) CA2156063C (de)
DE (2) DE69435106D1 (de)
DK (2) DK1473031T3 (de)
ES (2) ES2299173T3 (de)
HK (1) HK1056116A1 (de)
PT (2) PT738141E (de)
SG (1) SG43833A1 (de)
WO (1) WO1995016434A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2710854B1 (fr) * 1993-10-08 1995-12-01 Oreal Emulsion huile-dans-eau utilisable pour l'obtention d'une crème.
CA2273960C (en) * 1996-09-17 2003-12-30 Avanir Pharmaceuticals Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
AU780340B2 (en) * 1996-09-17 2005-03-17 Avanir Pharmaceuticals Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
WO1998026771A1 (en) * 1996-12-17 1998-06-25 Lidak Pharmaceuticals Use of c18 to c26 aliphatic alcohols for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
US5948822A (en) * 1996-12-17 1999-09-07 Lidak Pharmaceuticals Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
DE19718777A1 (de) * 1997-05-03 1998-11-05 Beiersdorf Ag Verwendung von Estern aus Fettsäuren und Di- und Oligosacchariden gegen die Adhäsion von Mikroorganismen
US6046244A (en) * 1997-11-05 2000-04-04 Nexmed Holdings, Inc. Topical compositions for prostaglandin E1 delivery
US6414028B1 (en) 1997-11-05 2002-07-02 Nexmed Holdings, Inc. Topical compositions containing prostaglandin E1
US20050203187A1 (en) * 1998-06-01 2005-09-15 Verbiscar Anthony J. Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof
ITMI981528A1 (it) * 1998-07-03 2000-01-03 Recordati Ind Chimica E Farma Formulazioni topiche di aciclovir
DE60020914T2 (de) 1999-09-03 2005-12-01 Cabby Business Inc., Road Town Effizientes Verfahren zur Herstellung sehr reiner Sterinen
DK1121928T3 (da) * 2000-01-31 2008-03-17 Haerting S A Sammensætninger indeholdende phytosterol- og policosanolestere af fedtsyrer til reduktion af niveauet af blodcholesterol og -triglycerider
PT102410A (pt) * 2000-02-03 2001-08-30 Qualitas Lab Extraccao da fraccao ceroide do residuo resinoso de fabricacao de aglomerado negro de cortica com fluido supercritico
US7399790B2 (en) 2001-02-28 2008-07-15 Konowalchuk Thomas W Virucidal compositions
PL371945A1 (en) * 2001-10-16 2005-07-11 Avanir Pharmacueticals Viral inhibition by n-docosanol
US6559182B1 (en) * 2001-11-07 2003-05-06 Purcell Jojoba International, Llc Method for treatment of enveloped viruses using jojoba oil esters
US7214394B2 (en) * 2002-05-31 2007-05-08 Archer-Daniels-Midland Company Policosanol compositions, extraction from novel sources, and uses thereof
GB0313830D0 (en) * 2003-06-16 2003-07-23 Unichema Chemie Bv Surfactant composition
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor
EP2132215B1 (de) 2007-02-28 2015-09-23 The Governors of the University of Alberta Stoffe zur vorbeugung oder behandlung von viralen infektionen und deren verwendung
US8715715B2 (en) 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
US20100209484A1 (en) * 2009-02-13 2010-08-19 Hoo-Kyun Choi Transdermal Triptan Delivery System
FR2949329B1 (fr) * 2009-08-31 2011-10-21 Oreal Composition cosmetique comprenant un alcane lineaire volatil et un ester de sucrose
CN102049050B (zh) * 2009-11-02 2014-06-18 重庆华邦制药有限公司 抗疱疹病毒感染的药物组合物
GB201207781D0 (en) 2012-05-03 2012-06-13 Restoration Of Appearance And Function Trust Extracellular matrix - synthetic skin scaffold
CN103877019B (zh) * 2013-10-31 2016-01-06 湖北科益药业股份有限公司 一种二十二醇乳膏
CN116583264A (zh) * 2020-12-14 2023-08-11 宝洁公司 包含蔗糖酯和溶剂的化妆品组合物
JP2023552814A (ja) * 2020-12-14 2023-12-19 ザ プロクター アンド ギャンブル カンパニー スクロースエステル及び溶媒を含む化粧品組成物の製造方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1459233A (en) * 1973-08-29 1976-12-22 Inst Rech Chim Biolog Medicament containing a higher alkanol
US4200655A (en) * 1978-08-15 1980-04-29 Sterling Drug Inc. Benzyl alcohol virucidal process
FR2492829A1 (fr) * 1980-10-24 1982-04-30 Oreal Agents de surface non-ioniques derives du glucose, procede pour les preparer et compositions les contenant
US4536519A (en) * 1981-06-15 1985-08-20 Kao Soap Co., Ltd. Emulsifying agent and emulsified cosmetics
US4670471A (en) * 1981-11-03 1987-06-02 Clark Lealand L Treatment for inflammatory skin disease
GB2122610B (en) * 1982-05-28 1987-04-01 Eisai Co Ltd A polyprenyl compound and a pharmaceutical composition containing a polyprenyl compound
EP0158108B1 (de) * 1984-03-05 1992-10-14 Tonfer Inc. Reinigungsmittel
US4684479A (en) * 1985-08-14 1987-08-04 Arrigo Joseph S D Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures
JPH0816066B2 (ja) * 1986-07-18 1996-02-21 エーザイ株式会社 持続性薬効製剤
JPS63179817A (ja) * 1987-01-19 1988-07-23 Kobayashi Kooc:Kk 水性クレンジング料
US4940586A (en) * 1987-02-26 1990-07-10 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4865848A (en) * 1987-02-26 1989-09-12 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4900555A (en) * 1987-02-26 1990-02-13 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US5070107A (en) * 1989-04-28 1991-12-03 Lidak Pharmaceuticals Systemic antiviral treatment
US4874794A (en) * 1989-04-28 1989-10-17 Lidak Biopharmaceuticals Inflammatory disease treatment
US4956171A (en) * 1989-07-21 1990-09-11 Paco Pharmaceutical Services, Inc. Transdermal drug delivery using a dual permeation enhancer and method of performing the same
US5166219A (en) * 1989-11-02 1992-11-24 Lidak Pharmaceuticals Systemic anti-inflammatory treatment
US5194451A (en) * 1989-11-02 1993-03-16 Katz David H Systemic anti-inflammatory treatment
JPH03157349A (ja) * 1989-11-14 1991-07-05 Lion Corp 乳化組成物
US5214071A (en) * 1991-04-23 1993-05-25 Summit Technology, Inc. Corneal treatment agents
US5098896A (en) * 1991-04-23 1992-03-24 Summit Technology, Inc. Corneal treatment agents
GB9204388D0 (en) * 1992-02-29 1992-04-15 Tioxide Specialties Ltd Water-in-oil emulsions

Also Published As

Publication number Publication date
DK0738141T3 (da) 2008-05-19
HK1056116A1 (en) 2004-02-06
EP0738141B1 (de) 2008-01-16
PT1473031E (pt) 2008-08-05
CA2156063C (en) 1999-06-29
ATE383848T1 (de) 2008-02-15
KR100322507B1 (ko) 2002-08-14
DE69435067D1 (de) 2008-03-06
JP4149511B2 (ja) 2008-09-10
EP1473031B1 (de) 2008-06-25
WO1995016434A1 (en) 1995-06-22
JP2006206610A (ja) 2006-08-10
CN1223342C (zh) 2005-10-19
CN1419911A (zh) 2003-05-28
US5534554A (en) 1996-07-09
DE69435067T2 (de) 2008-05-15
EP0738141A1 (de) 1996-10-23
PT738141E (pt) 2008-02-11
ATE399004T1 (de) 2008-07-15
ES2299173T3 (es) 2008-05-16
CN1103586C (zh) 2003-03-26
AU693476B2 (en) 1998-07-02
JPH09506612A (ja) 1997-06-30
DE69435106D1 (de) 2008-08-07
AU7719294A (en) 1995-07-03
EP0738141A4 (de) 1998-01-07
EP1473031A1 (de) 2004-11-03
CN1142764A (zh) 1997-02-12
CA2156063A1 (en) 1995-06-22
ES2309441T3 (es) 2008-12-16
DK1473031T3 (da) 2008-10-20

Similar Documents

Publication Publication Date Title
SG43833A1 (en) Sucrose ester-c20 to c25 alcohol formulations
EP0253600A3 (en) Bismaleimide formulations containing olefinic ether modifiers
DE69004731D1 (de) Hilfsmittel enthaltende verdünnbare Formulierungen von Nachlaufherbiziden.
HK5996A (en) 2-substituted-4-substituted-1,3-dioxolanes synthesis and use thereof
GB9005523D0 (en) Cosmetic composition
ES542447A0 (es) "un procedimiento para preparar un derivado de cefem".
DK0407815T3 (da) Præparat indeholdende polyprenylforbindelser til bløde kapsler
ES2069765T3 (es) Nuevos derivados del acido 2,2-dimetil-ciclopropenocarboxilico que llevan en posicion 3 una cadena halogenada saturada, su procedimiento de preparacion y su aplicacion en la sintesis de productos plaguicidas.
ES540757A0 (es) Un procedimiento para activar peroxido de hidrogeno
ES2003063A4 (es) Derivados de pirrolidin-2-ona, que tengan actividad nootropica.
IE872578L (en) Antigestagen compositions
AU569164B2 (en) Bis (triphenylphosphine)-hydrazinomethoxy rhodium
DE3879792D1 (de) Gerichtete-biosynthese eines milbemycinanaloges.
ES2024632B3 (es) Caseta de separacion.
ATE148706T1 (de) Pradimicin-derivate
IT1223169B (it) Procedimento per la preparazione di monoeteri di idrochinoni
GB8700837D0 (en) Prostaglandin synthesis
JPS56161377A (en) Preparation of 1,4-bis 3-hydroxypropyl hexahydro-1h-1,4- diazepine
ES2042683T3 (es) Composiciones aromaticas conteniendo un derivado de anisol halogenado.
JPS5346926A (en) Preparation of 6-methyl-2,3,4-trimethoxyphenol
KR900015583U (ko) 경운기의 조작레버구조
UA11669A1 (uk) Стимулятор росту сіяhців сосhи звичайhої
FI864796A (fi) Komposition vilken foerhindrar patologisk alkoholaddiktion.
DE69200523T2 (de) Polyglukosiden aus Hydroxyalkylsorbit.
ITBO910037A0 (it) Fustellato a nuova conformazione per l'ottenimento di un pacchetto hinge-lid a perfetta planarita'.